Clinical Trials
23 trialsNCT05823714 2023-04-21
Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT
The First Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT04906031 2021-06-09
Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations
First Affiliated Hospital of Jinan University
Phase 2 Unknown
NCT01894477 2021-06-03
Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Fred Hutchinson Cancer Center
Phase 2 Unknown
NCT02124174 2021-04-26
Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS
Loyola University
Phase 2 Unknown
NCT02856464 2020-04-02
PRO-DLI
King's College Hospital NHS Trust
Phase 2 Unknown
NCT01240525 2019-02-12
ProT4
University College, London
Phase 2 Unknown
NCT03454984 2018-11-15
SGI-110 and Donor Lymphocyte Infusions (DLI) After Allogeneic Stem Cell Transplantation
Groupe Francophone des Myelodysplasies
Phase 2 Unknown
NCT03356080 2017-11-29
DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Excess
Shanghai Tong Ren Hospital
Phase 2 Unknown
NCT02799888 2016-06-15
Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation
Affiliated Hospital to Academy of Military Medical Sciences
Phase 2 Unknown
NCT00885508 2015-04-24
GFM-Chimio-Rev
Groupe Francophone des Myelodysplasies
Phase 2 Unknown
NCT00084695 2014-01-10
Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00008307 2014-01-06
Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00008164 2013-12-18
Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00003827 2013-12-04
Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00003885 2013-11-06
Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00036712 2013-09-20
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01556477 2012-03-16
The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).
Nordic MDS Group
Phase 2 Unknown
NCT01133886 2010-09-03
DEC-MDS
King's College London
Phase 2 Unknown
NCT00598624 2009-08-11
AlloTreo
IRCCS San Raffaele
Phase 2 Unknown
NCT00466843 2009-06-02
Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome
Office of Rare Diseases (ORD)
Phase 2 Unknown
NCT00304720 2008-02-08
Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor
Colorado Blood Cancer Institute
Phase 2 Unknown
NCT00328237 2006-06-26
Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation
Colorado Blood Cancer Institute
Phase 2 Unknown
NCT00153582 2006-02-22
WT1 Peptide Vaccination in Acute Myeloid Leukemia (AML)
Charite University, Berlin, Germany
Phase 2 Unknown